Sawyer & Company, Inc Ironwood Pharmaceuticals Inc Transaction History

Sawyer & Company, Inc

  • $270 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 19, 2023
SELL
$10.37 - $12.56 $197,548 - $239,268
-19,050 Reduced 63.5%
10,950 $117,000
Q4 2022

Jan 11, 2023
SELL
$9.9 - $12.43 $108,900 - $136,730
-11,000 Reduced 26.83%
30,000 $372,000
Q4 2017

Jan 11, 2018
BUY
$12.16 - $14.58 $498,560 - $597,780
41,000
41,000 $615,000

Others Institutions Holding IRWD

# of Institutions
240
Shares Held
161M
Call Options Held
11.2M
Put Options Held
19.2K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $294M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Sawyer & Company, Inc Portfolio

Follow Sawyer & Company, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawyer & Company, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sawyer & Company, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email